Deloittes committed to Huntingdon
Deloitte & Touche has confirmed that it will continue to act as auditor of embattled drug-testing group Huntingdon Life Sciences.
The news followed HSBC’s decision to cut ties with the company.
The bank is to drop its stake of nearly one per cent in the company which it held on behalf of some clients in a nominee account following pressure from an anti-vivisection group, Stop Huntingdon Animal Cruelty.
A spokesman for Deloittes confirmed the firm had no plans to resign from the audit, adding: ‘We are surprised to have even been asked the question.’
The firm said that it had not recently been the target of any action from the animal rights group.
Since the beginning of the campaign, HLS has seen its share price fall, the sale of an 11% stake held by Phillips & Drew and the departure of its broker WestLB Panmure.